Houston's MD Anderson Cancer Center and Memorial Hermann treat substantial numbers of multiple myeloma patients requiring Lenalidomide-based therapy. Lenalid 25mg, the Indian generic of Revlimid, now makes this treatment dramatically more affordable following patent expiry.
Lenalid is an immunomodulatory drug (IMiD) that stimulates immune attack on myeloma cells while inhibiting new blood vessel formation tumours need to grow. It's used with dexamethasone for relapsed/refractory disease, and as maintenance therapy after stem cell transplant, where it significantly extends progression-free survival.
Brand Revlimid costs over $20,000 monthly — one of the most expensive cancer medicines in the USA. Generic Lenalid from WHO-GMP certified manufacturers provides identical efficacy at savings of thousands of dollars monthly.
Lenalid is an immunomodulatory drug (IMiD) that stimulates immune attack on myeloma cells while inhibiting new blood vessel formation tumours need to grow. It's used with dexamethasone for relapsed/refractory disease, and as maintenance therapy after stem cell transplant, where it significantly extends progression-free survival.
Brand Revlimid costs over $20,000 monthly — one of the most expensive cancer medicines in the USA. Generic Lenalid from WHO-GMP certified manufacturers provides identical efficacy at savings of thousands of dollars monthly.
Why does Lenalid require pregnancy testing and contraception monitoring?Lenalidomide carries a serious risk of severe birth defects if taken during pregnancy, similar to its related compound thalidomide. Because of this, all patients of childbearing potential must follow a strict risk management program (REMS in the US) requiring regular pregnancy tests and confirmed use of effective contraception throughout treatment and for a period afterward. This applies to female patients taking the drug and to male patients' partners, since Lenalidomide is present in semen.
